Progress on dietary therapy for gout and hyperuricemia

Progress on dietary therapy for gout and hyperuricemia

This review briefs the anti-hyperuricemia(HUA) mechanism of nutrition targeting the gut, such as the gut microbiota promoting the catabolism of purine and uric acid(UA), and increased its metabolites like uric acid. The review also summarizes the probiotics and prebiotics that have the effect of low...

Full description

Saved in:

Bibliographic Details
Main Author:	JIN Lei, WU Qianqian, ZHANG Xiaomin, GUO Jie, WANG Feng
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2025-03-01
Series:	Jichu yixue yu linchuang
Subjects:	gout\|hyperuricemia\|dietary factor\|nutrition\|body mass index
Online Access:	https://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2025-45-3-281-382.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The gut microbiome: a vital link to hyperuricemia, gout and acute flares?
by: Wei Wang, et al.
Published: (2025-08-01)

NEW OPPORTUNITIES FOR CORRECTION OF HYPERURICEMIA IN GOUT
by: Svetlana Evgenyevna Myasoedova, et al.
Published: (2009-12-01)

Mechanisms of cartilage damage in gout and hyperuricemia
by: E. V. Panina
Published: (2024-04-01)

Transcriptomic Analysis of Peripheral Blood Mononuclear Cells in Hyperuricemia and Gout
by: Valentin NICA, et al.
Published: (2025-05-01)

Epidemiological perspectives on emerging contaminants and gout or hyperuricemia
by: Weiwen Fu, et al.
Published: (2025-06-01)

Features of diet in patients with cardiometabolic diseases with gout and hyperuricemia: A review
by: Margarita A. Gromova, et al.
Published: (2025-01-01)

Asymptomatic hyperuricemia and gout: Are there any differences (data from a pilot case-control study)
by: M. S. Eliseev, et al.
Published: (2025-07-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part I: the current state of the problem
by: M. S. Eliseev, et al.
Published: (2022-10-01)

Awareness of Gout and Hyperuricemia in a Sample of the Adult Population in Iraq
by: Shaimaa Jubair, et al.
Published: (2022-06-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
by: M. S. Eliseev, et al.
Published: (2022-12-01)

Hyperuricaemia and Gout: A Review
by: Amy Kopke, et al.
Published: (2010-04-01)

Hyperuricemia: Features of the Diet
by: O. B. Shvabskaia, et al.
Published: (2022-01-01)

Association between visceral adiposity index and hyperuricemia and gout among US adults: a cross-sectional analysis of NHANES 2007–2018
by: Mingjie Tang, et al.
Published: (2025-07-01)

Comparison of colorimetric and electrochemical (Easy Touch GCU Meter) methods for determination of blood uric acid in clinical practice in patients with gout and hyperuricemia (data from a pilot study)
by: M. S. Eliseev, et al.
Published: (2023-10-01)

Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
by: O.P. Bortkevych, et al.
Published: (2025-06-01)

Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

The relationship between dietary index for gut microbiota and hyperuricemia: a cross-sectional study using NHANES data
by: Xin Cai, et al.
Published: (2025-05-01)

NEW INTERNATIONAL RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF GOUT
by: M. S. Eliseev
Published: (2014-06-01)

Impact of alcohol consumption on hyperuricemia and gout: a systematic review and meta-analysis
by: Weiwei Ma, et al.
Published: (2025-05-01)

Associations of circadian syndrome with gout and hyperuricemia: a cross‑sectional analysis of NHANES 2007–2018
by: Jun-Wei Ren, et al.
Published: (2025-06-01)

The diagnosis, treatment and prevention of gout: The 2014 international clinical guidelines
by: N. T. Vatutin, et al.
Published: (2015-09-01)

USE OF HERBAL REMEDY URISAN AS BASIC THERAPY FOR GOUT
by: Tamila Nilovna Khalfina, et al.
Published: (2010-06-01)

Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
by: M. S. Eliseev, et al.
Published: (2024-10-01)

Interpretive prediction of hyperuricemia and gout patients via machine learning analysis of human gut microbiome
by: Jia-Wei Tang, et al.
Published: (2025-07-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
by: Ryutaro Iwama, et al.
Published: (2024-12-01)

Premature mortality with gout and hyperuricemia may be reduced by early resolution of comorbid obstructive sleep apnea
by: Burton Abrams
Published: (2023-08-01)

Case Report: Intradural gout tophi without systemic gout symptoms
by: Peidong Qing, et al.
Published: (2025-02-01)

Tophaceous Gout
by: Yunxin Liu, et al.
Published: (2025-02-01)

DIET IN GOUT AND HYPERURICEMIA
by: O. V. Zhelyabina, et al.
Published: (2017-09-01)

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system
by: Guihao Zheng, et al.
Published: (2025-07-01)

Genetics of hyperuricemia and gout: Insights from recent genome-wide association studies and Mendelian randomization studies
by: Yu-Lin Ko
Published: (2022-01-01)

Management of gout in advanced renal disease
by: John S. Richards, et al.
Published: (2025-05-01)

Hyperuricemia, gout and comorbidity
by: N. A. Shostak, et al.
Published: (2023-01-01)

THE HERBAL COMPLEX URISAN IS THE HELP TO A PHYSICIAN TREATING A PATIENT WITH GOUT
by: I I Polskaya, et al.
Published: (2009-09-01)

Determining the Frequency of Metabolic Syndrome in Gout Patients in Rheumatology Clinics of Sari in 2023-24
by: Hengameh Babaee, et al.
Published: (2025-07-01)